Insider Transactions in Q1 2023 at Bicycle Therapeutics PLC (BCYC)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 03
2023
|
Veronica Gh Jordan Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,750
+34.85%
|
-
|
|
Jan 03
2023
|
Alistair Milnes CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
1,801
-4.5%
|
$52,229
$29.06 P/Share
|
|
Jan 03
2023
|
Alistair Milnes CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
17,500
+30.45%
|
-
|
|
Jan 03
2023
|
Nigel Crockett CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
1,801
-5.54%
|
$52,229
$29.06 P/Share
|
|
Jan 03
2023
|
Nigel Crockett CHIEF BUSINESS OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
17,500
+35.0%
|
-
|
|
Jan 03
2023
|
Gregory Paul Winter Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,750
+3.19%
|
-
|
|
Jan 03
2023
|
Janice Bourque Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,750
+34.85%
|
-
|
|
Jan 03
2023
|
Lee Kalowski President and CFO |
SELL
Open market or private sale
|
Direct |
1,815
-5.58%
|
$52,635
$29.06 P/Share
|
|
Jan 03
2023
|
Lee Kalowski President and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
17,500
+35.0%
|
-
|
|
Jan 03
2023
|
Nicholas Keen CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
1,817
-4.43%
|
$52,693
$29.06 P/Share
|
|
Jan 03
2023
|
Nicholas Keen CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
17,500
+29.93%
|
-
|
|
Jan 03
2023
|
Michael Skynner CHIEF TECHNOLOGY OFFICER |
SELL
Open market or private sale
|
Direct |
1,801
-2.45%
|
$52,229
$29.06 P/Share
|
|
Jan 03
2023
|
Michael Skynner CHIEF TECHNOLOGY OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
17,500
+19.2%
|
-
|
|
Jan 03
2023
|
Dominic Smethurst Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,801
-4.68%
|
$52,229
$29.06 P/Share
|
|
Jan 03
2023
|
Dominic Smethurst Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,500
+31.25%
|
-
|
|
Jan 03
2023
|
Pierre Legault Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,500
+34.85%
|
-
|
|
Jan 03
2023
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
6,000
-1.8%
|
$174,000
$29.06 P/Share
|
|
Jan 03
2023
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
57,500
+14.74%
|
-
|
|
Jan 03
2023
|
Jose Carlos Gutierrez Ramos Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,750
+34.85%
|
-
|
|
Jan 03
2023
|
Richard N Kender Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,750
+34.85%
|
-
|